ICP L28: Management of patients with gingivitis and periodontitis Flashcards
Outline the pathogenesis of periodontal disease
It is exaggerated and poorly effective non-resolving inflammation of the connective tissues supporting teeth leading to tooth destruction which is mediated by an inflammatory immune response to bacteria in the oral biofilm
What factors can make the host more susceptible to periodontitis
Genetics - congenital detects in immunity, age
Systemic disease - DM, obesity, CVD, immunodeficiency
Environmental - smoking, diet, stress
Outline the signs and symptoms of gingivitis
Inflammation of the gums due to plaque accumulation characterised by: erythema, oedema, tenderness, enlargement, swelling, redness and some complain of halitosis, altered taste, difficulty eating and reduced QoL
There is bleeding on probing with no bone loss (therefore it is reversible) - X-rays do not aid diagnosis
Define a case of periodontitis
- Interdental attachment loss is detectable at >=2 non-adjacent teeth or
- Buccal/ oral attachment loss >=3mm with pocketing >=3mm is detectable at >=2 teeth
What causes other then periodontitis can CAL be a result of
Clinical attachment loss can occur due to
- Gingival recession of traumatic origin
- Dental caries extending into cervical area of tooth
- Presence of CAL on distal aspect of second molar associated with malposition/extraction of third molar
- Endodontic lesion draining through the marginal periodontium
- Vertical root fracture
Outline the signs and symptoms of periodontitis
- Supra/sub gingival plaque/calculus accumulation
- Erythema, oedema, tenderness, enlargement, swelling, redness, suppuration (pus out of sulcus), gum recession, halitosis
- Pocket formation, bleeding on probing and suppuration
- Loss of periodontal attachment
- Irreversible loss
Describe probing on health teeth
In health the tooth is surrounded by a sulcus - the JE forms the base of the sulcus by attaching to the enamel of the crown near the CEJ
Depth = 1-3mm
Describe probing on a diseased tooth
A periodontal pocket (deepened gingival sulcus) due to disease - the JE forms the base of the pocket by attaching to the root surface apical to CEJ
Depth = >3mm
Define PPD
Probing pocket depth = distance from gingival margin to tip of probe (cannot be sure if probe reaches base of sulcus)
Define PAL/CAL
Probing/Clinical attachment loss = distance from CEJ to tip of probe this needs measurement between free gingival margin and CEJ :
PAL/CAL = [ PPD - (CEJ-FGM) ]
Define gingival recession
Distance from gingival margin to CEJ, when gingival margin is apical to CEJ = negative, when gingival margin is coronal to CEJ = positive (due to pseudo pocket - gingival overgrowth)
What are the therapeutic objectives of gingivitis
- Control risk factors
- Improve patients compliance and effectiveness of oral hygiene by motivating patient to achieve successful removal of supra gingival dental biofilm (FMPS <20%)
- Reduce/eliminate gingival inflammation (FMBS <10%)
What are the therapeutic objectives of periodontitis
- FMPS <20%
- FMBS <10%
- Stop periodontitis progression and reduce PPD - the aim is to reach closed pockets (no PPD>4mm and BoP)
Outline the step wise approach for periodontitis treatment (each new stage includes the previous one)
- Behavioural change by motivating patient to remove supra gingival biofilm and control risk factors
- Control sub gingival biofilm and calculus (sub gingival instrumentation)
- Treat >=4mm PPD with BoP/deep pockets >=6mm to gain further access to sub gingival instrumentation/ aim at regeneration or resecting the residual lesions
- Supportive periodontal care aimed at maintaining periodontal stability by combining preventative and therapeutic interventions
Outline step 1 of periodontitis therapy
- supra gingival biofilm control : mechanical and chemical
- interventions to improve effectiveness of oral hygiene
- adjunctive therapies for gingival inflammation
- professional mechanical plaque removal (hygienists using a scaler, curette and sonic/ultrasonic instruments)
- risk factor control
= foundation for optimal treatment response and long-term stable outcomes